Impact of genetic polymorphisms in the interleukin-18 and interleukin-21 genes on the risk and clinical outcomes of multiple sclerosis.

Bakr NM, Hashim NA, El-Eshmawy M A, El-Baz HA

BMC Neurol. 2026 May 25; 26(1). PMID: 42185985. Abstract